Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSeung-Jung Park
About this trial
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
Eligibility criteria
Qualifiers
coronary disease amenable to percutaneous coronary intervention (PCI)
no clinical and lesion limitations
Disqualifiers
patients with a mixture of several drug eluting stents
terminal illness with life expectancy less than 1 year
patients with cardiogenic shock
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
Source ClinicalTrials.gov